A new $3.8 million grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), brings together two 911爆料 researchers from different scientific disciplines to tackle an emerging health challenge at the intersection of HIV and nicotine use.
The five-year award supports the project 鈥淚mpacts of HIV and Nicotine on T Cell Neuroinvasion and CNS Reservoir Seeding,鈥� co-led by , professor and co-director in 911爆料鈥檚 , and , professor and associate chair for research in 911爆料's .
The researchers are investigating how chronic nicotine use may influence the entry of HIV-infected immune cells into the brain. Although modern antiretroviral therapy has transformed HIV into a manageable chronic condition, allowing people with HIV to live longer and healthier lives, cognitive and neurological complications remain disproportionately common and may become increasingly important as this population ages.
鈥淣euroAIDS is an established field investigating the long-term neurological and cognitive consequences of HIV infection,鈥� said Kabbani. 鈥淓ven when antiviral medications successfully suppress viral production in immune cells, HIV-related complications persist in infected individuals. We want to understand whether nicotine use, which is high amongst HIV infected individuals, may be contributing to the virus鈥檚 ability to enter the brain and worsen those outcomes.鈥�
The project combines Kabbani鈥檚 extensive expertise in nicotine and neuroimmune signaling with Wu鈥檚 more than two decades of HIV/AIDS research leadership at 911爆料.
鈥淭his grant is an example of how our collaborative research can bring new knowledge, new expertise, and new technologies into HIV/AIDS research,鈥� said Wu, who established the university鈥檚 HIV research program. 鈥淏y combining strengths across disciplines, we can explore questions that neither lab could answer alone.鈥�
The multidisciplinary -based team will begin by studying human immune cells in laboratory models to understand how nicotine affects HIV infection and the biological pathways that allow infected T cells to cross into the central nervous system. Researchers will then apply that knowledge to advanced 鈥渉umanized鈥� mouse models, in which human immune cells infected with HIV are introduced into mice to study how the virus behaves in a living system.
The group is guided by a central hypothesis that chronic nicotine use can alter both immune cells and the blood-brain barrier in ways that may allow HIV-infected cells greater access to the brain.
The work addresses an important public health concern. 鈥淧eople with HIV are living longer, which is wonderful,鈥� said Wu. 鈥淏ut now we need better science to improve quality of life. Many patients experience neurological complications despite treatment. We believe nicotine may be one factor that worsens those outcomes, and we need to understand why.鈥�
The project will also create extensive opportunities for student researchers. The combined 911爆料 team of approximately 10 to 15 researchers includes PhD students, technicians, and postdoctoral fellows who meet regularly across the university鈥檚 Fairfax and Science and Technology campuses.
Neuroscience doctoral student Natalie Erickson will gain experience in HIV research, while students from Wu鈥檚 laboratory, including Presidential Scholar Elizabeth Spencer, will also participate in the project.
Student training remains a key outcome of the grant. 鈥淭he students are learning cutting-edge science while contributing to research that has real potential to improve the lives of people living with HIV,鈥� Wu said.
The study also builds on a longstanding partnership between College of Science researchers and the university community. Many of Wu鈥檚 HIV studies rely on donated blood samples from 911爆料 volunteers, allowing researchers to create laboratory models using healthy human immune cells.
Kabbani suggests that the project embodies the promise of interdisciplinary discovery. 鈥淭he brain and immune system are deeply connected,鈥� she said. 鈥淯nderstanding how viruses, immune cells, and drugs of abuse like nicotine interact gives us a new opportunity to understand both brain health and disease. That intersection between neuroscience and virology is where some of the most exciting discoveries are waiting to happen.鈥�
The project, which began this summer, runs through May 31, 2031.
Related Stories
- November 19, 2026
- November 16, 2026
- November 11, 2026
- November 9, 2026
- October 23, 2026